CIK 0000939767 · Large accelerated filer
EXELIXIS, INC.
Sign in to watch- Ticker
- EXEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jan 1
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043257395
- Phone
- 6508377000
- Business address
- 1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
- Former names
- EXELIXIS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-15 | Haley Patrick J. EVP, Commercial | Sale 10b5-1 | −10,000 | $46.95 | $470K | 446,459 |
| 2025-05-15 | Haley Patrick J. EVP, Commercial | Option exercise 10b5-1 | +116,383 | $18.80 | $2.2M | 562,842 |
| 2025-05-15 | Haley Patrick J. EVP, Commercial | Sale 10b5-1 | −116,383 | $48.05 | $5.6M | 446,459 |
| 2025-05-15 | Haley Patrick J. EVP, Commercial | Option exercise · Option (right to buy) 10b5-1 | −116,383 | 0 | ||
| 2025-05-15 | Peterson Amy C. EVP Prod Dev & Med Aff & CMO | Shares withheld for taxes | −8,303 | $44.65 | $371K | 498,169 |
| 2025-05-14 | MORRISSEY MICHAEL President and CEO | Option exercise | +308,365 | $18.80 | $5.8M | 1,931,374 |
| 2025-05-14 | MORRISSEY MICHAEL President and CEO | Shares withheld for taxes | −220,494 | $44.65 | $9.8M | 1,710,880 |
| 2025-05-14 | MORRISSEY MICHAEL President and CEO | Option exercise · Option (right to buy) | −308,365 | 0 | ||
| 2025-05-14 | Haley Patrick J. EVP, Commercial | Sale 10b5-1 | −10,000 | $42.68 | $427K | 491,164 |
| 2025-05-01 | Aftab Dana CSO/EVP Disc & Trans Research | Sale 10b5-1 | −1,508 | $39.00 | $59K | 693,181 |
| 2025-03-31 | Peterson Amy C. EVP Prod Dev & Med Aff & CMO | Grant or award | +159,383 | 506,472 | ||
| 2025-03-31 | MORRISSEY MICHAEL President and CEO | Grant or award | +589,719 | 1,623,009 | ||
| 2025-03-31 | Aftab Dana CSO/EVP Disc & Trans Research | Grant or award | +132,819 | 693,936 | ||
| 2025-03-31 | Hessekiel Jeffrey EVP & General Counsel | Grant or award | +154,070 | 751,678 | ||
| 2025-03-31 | Haley Patrick J. EVP, Commercial | Grant or award | +159,383 | 500,411 | ||
| 2025-03-31 | Senner Christopher J. EVP and CFO | Grant or award | +170,009 | 1,009,264 | ||
| 2025-03-03 | Haley Patrick J. EVP, Commercial | Sale 10b5-1 | −10,000 | $38.80 | $388K | 341,028 |
| 2025-02-28 | Smith Julie Director | Option exercise | +19,294 | $19.77 | $381K | 30,072 |
| 2025-02-28 | Smith Julie Director | Sale | −19,294 | $37.62 | $726K | 10,778 |
| 2025-02-28 | Smith Julie Director | Option exercise · Option (right to buy) | −19,294 | 0 |
Page 8 of 10 · 192 trades